Aktieanalys

Lifeclean Q1’2024: Sales in line - Redeye

Redeye 07 May 09:32

Redeye saw sales that were just above and results that were below our expectations. Sales were up 10% y/y and up the previous quarter, while costs were higher than expected again. The sales development is a positive factor. With the share issue and increased debt, the cash at hand at the end of the quarter stands at SEK 18.m. We will likely maintain our sales estimates for the rest of the year while increasing costs. The Base case will be adjusted slightly downwards as we change the cost levels while we still see that the agreements made recently have not yet reached the potential, which holds back any major negative revisions.

Länk till analysen i sin helhet: https://www.redeye.se/research/1003738/lifeclean-q12024-sales-in-line?utm_source=finwire&utm_medium=RSS

Börskollens app – Högt betyg ⭐⭐⭐⭐⭐ och 250.000 nedladdningar

Ladda hem

Vårt nyhetsbrev – Utvalda börsnyheter och heta investeringscase varje vecka

Prenumerera

Nyheter om Lifeclean

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!